Key points from article :
Biotech firm Arcis Biotechnology, based in Daresbury, UK, has signed a new distribution agreement with Opentrons, a U.S.-based company known for its affordable lab automation robots. The deal will integrate Arcis’ rapid nucleic acid extraction and preservation technologies with the Opentrons OT-2 platform, enabling more laboratories to automate DNA and RNA sample preparation efficiently and affordably.
Arcis develops products for a wide range of biotech applications, from molecular diagnostics to agriculture and hygiene. Its two-step process allows for quicker, more accurate testing from various sample types, which is particularly useful in time-sensitive fields like disease detection and forensic science.
With this agreement, Arcis’ reagents can now be used seamlessly on the OT-2 robot, which automates pipetting tasks and simplifies lab protocols. Arcis CEO Peter Whitehurst highlighted that the collaboration responds to scientist demand for higher sample processing capacity, while Opentrons’ co-founder Will Canine emphasized the potential to accelerate scientific workflows and discovery.
This partnership reflects a broader move toward lab automation and accessibility, bringing advanced biotech tools to a wider range of researchers and institutions without high-end resources or infrastructure.
